Year: 2005
Type: review
Study designs: Systematic Review, Meta-Analysis
Abstract: BACKGROUND: Increasing attention has been given by researchers to cannabis use in individuals with psychosis. As psychoses are relatively low-prevalence disorders, research has been mostly been restricted to small-scale studies of treatment samples. The reported prevalence estimates obtained from these studies vary widely. AIMS: To provide prevalence estimates based on larger samples and to examine sources of variability in prevalence estimates across studies. METHOD: Data from 53 studies of treatment samples and 5 epidemiological studies were analysed. RESULTS: Based on treatment sample data, prevalence estimates were calculated for current use (23.0%), current misuse (11.3%), 12-month use (29.2%), 12-month misuse (18.8%), lifetime use (42.1%) and lifetime misuse (22.5%). Epidemiological studies consistently reported higher cannabis use and misuse prevalence in people with psychosis. CONCLUSIONS: The factor most consistently associated with increased odds of cannabis prevalence was specificity of diagnosis. Factors such as consumption patterns and study design merit further consideration.
Authors: Bob Green, Ross Young, David Kavanagh
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2099789990
